摘要:
Compounds of formula (I) wherein W is -OH or -NHOH; X is an optionally substituted heterocycle, NR1SO2R2, heterocyclylalkythio, CONR2R3 or NR1COR2; Y, Z, R1-R3 and n are as defined in the application. Compounds (I) are inhibitors of matrix-degrading metalloproteinases and are use for the treatment of related conditions.
摘要翻译:其中W是-OH或-NHOH的式(I)化合物; X是任选取代的杂环,NR 1 SO 2 R 2,杂环基炔基,CONR 2 R 3或NR 1 COR 2; Y,Z,R 1 -R 3和n如本申请中所定义。 化合物(I)是基质降解金属蛋白酶的抑制剂,用于治疗相关病症。
摘要:
A compound of formula (I), useful for the treatment of cancer, inflammation and inflammatory disorders, and a pharmaceutical composition containing the compound.
摘要:
The present invention provides certain sulfonamide derivatives useful for potentiating glutamate receptor function in a mammal and therefore, useful for treating a wide variety of conditions, such as psychiatric and neurological disorders.
摘要:
The present invention concerns compounds and their use to inhibit the activity of a receptor tyrosine kinase. The invention is preferably used to treat cell proliferative disorders such as cancers characterized by over-activity or inappropriate activity HER2 or EGFR.
摘要:
Compounds according to Formula (I) are provided and salts thereof, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 13 , A, X and Y are as defined herein. Methods for preparing compounds of Formula (I) are also provided, as well as methods of treating cellular proliferative disorders, such as cancer, using compounds of Formula (I).
摘要:
There is provided compounds of formula (I), wherein ring A, D1, D2a, D2b, D3, L1, Y1, L3 and Y3 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of leukotriene C4 synthase is desired and/or required, and particularly in the treatment of a respiratory disorder and/or inflammation.
摘要:
This invention relates to sulfonamide derivatives of formula (Ia) (in which R is -CH(R )Ar or -CH(R )CH=CHAr , and the other variables are as defined in the claims) that are inhibitors of procollagen C-proteinase, pharmacological compositions containing them, their use, intermediates and methods for preparing these compounds.
摘要:
Aryloxyaniline derivatives represented by the general formula (I), wherein Ar and Ar represent each a substituted or unsubstituted phenyl, pyridyl, or naphthyl group; R represents a hydrogen atom, an alkyl group or the like; X represents a hydrogen atom, an alkyl group or the like; and Y represents a branched or unbranched 1-6 C alkylene group or a single bond, or pharmaceutically acceptable salts thereof. The derivatives can provide medicines having high affinity for MDR exhibiting therapeutic and prophylactic effects on anxiety and associated diseases, depression, and the like.
摘要翻译:由通式(I)表示的芳氧基苯胺衍生物,其中Ar 1和Ar 2各自表示取代或未取代的苯基,吡啶基或萘基; R 1表示氢原子,烷基等; X 1表示氢原子,烷基等; Y 1表示支链或非支链的1-6C亚烷基或单键,或其药学上可接受的盐。 该衍生物可以提供对MDR具有高亲和力的药物,其表现出对焦虑和相关疾病,抑郁症等的治疗和预防作用。
摘要:
There is provided compounds of formula (I), wherein ring A, D 1 , D 2a , D 2b , D 3 , L 1 , Y 1 , L 3 and Y 3 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of leukotriene C 4 synthase is desired and/or required, and particularly in the treatment of a respiratory disorder and/or inflammation.
摘要:
Substituted phenol derivatives of Formula (I) are useful as antiproliferative agents including, for example, anticancer agents, and as radioprotective and chemoprotective agents.